Correlation Between CSL and Vertex Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both CSL and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CSL and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CSL LTD SPONADR and Vertex Pharmaceuticals Incorporated, you can compare the effects of market volatilities on CSL and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CSL with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of CSL and Vertex Pharmaceuticals.
Diversification Opportunities for CSL and Vertex Pharmaceuticals
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between CSL and Vertex is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding CSL LTD SPONADR and Vertex Pharmaceuticals Incorpo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and CSL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CSL LTD SPONADR are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of CSL i.e., CSL and Vertex Pharmaceuticals go up and down completely randomly.
Pair Corralation between CSL and Vertex Pharmaceuticals
Assuming the 90 days trading horizon CSL LTD SPONADR is expected to under-perform the Vertex Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, CSL LTD SPONADR is 1.4 times less risky than Vertex Pharmaceuticals. The stock trades about -0.14 of its potential returns per unit of risk. The Vertex Pharmaceuticals Incorporated is currently generating about 0.41 of returns per unit of risk over similar time horizon. If you would invest 39,505 in Vertex Pharmaceuticals Incorporated on November 4, 2024 and sell it today you would earn a total of 5,010 from holding Vertex Pharmaceuticals Incorporated or generate 12.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
CSL LTD SPONADR vs. Vertex Pharmaceuticals Incorpo
Performance |
| Timeline |
| CSL LTD SPONADR |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Vertex Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Weak
CSL and Vertex Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CSL and Vertex Pharmaceuticals
The main advantage of trading using opposite CSL and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CSL position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.The idea behind CSL LTD SPONADR and Vertex Pharmaceuticals Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Vertex Pharmaceuticals vs. UPDATE SOFTWARE | Vertex Pharmaceuticals vs. UNIVMUSIC GRPADR050 | Vertex Pharmaceuticals vs. UNIVERSAL MUSIC GROUP | Vertex Pharmaceuticals vs. Beta Systems Software |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |